Old Web
English
Sign In
Acemap
>
authorDetail
>
Roy M. Pollock
Roy M. Pollock
Immunology
Medicine
Monetary economics
Lymphoma
Equity (finance)
3
Papers
57
Citations
0.03
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
EZH2 Inhibitor EPZ-6438 Synergizes With Anti-Lymphoma Therapies In Preclinical Models
2013
Blood
L. Danielle Johnston
Sarah K. Knutson
Natalie Warholic
Christine R. Klaus
Tim J. Wigle
Dorothy Iwanowicz
Bruce A. Littlefield
Margaret Porter-Scott
J. Joshua Smith
Mikel P. Moyer
Robert A. Copeland
Roy M. Pollock
Kevin Wayne Kuntz
Heike Keilhack
Alejandra Raimondi
Show All
Source
Cite
Save
Citations (4)
DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs or DNA Hypomethylating Agents in MLL -Rearranged Leukemia Cells
2013
Blood
Christine R. Klaus
Scott R. Daigle
Dorothy Iwanowics
L. Danielle Johnston
Carly A. Therkelsen
J. Joshua Smith
Mikel P. Moyer
Robert A. Copeland
Edward J. Olhava
Margaret Porter-Scott
Roy M. Pollock
Alejandra Raimondi
Show All
Source
Cite
Save
Citations (3)
Identification and purification of EBP1: a HeLa cell protein that binds to a region overlapping the 'core' of the SV40 enhancer.
1988
Genes & Development
Lilian Clark
Roy M. Pollock
Ronald T. Hay
Show All
Source
Cite
Save
Citations (50)
1